Timing of SGLT2i initiation after acute myocardial infarction

Timing of SGLT2i initiation after acute myocardial infarction

Abstract Background Pharmacological post-MI treatment is routinely initiated at intensive/cardiac care units. However, solid evidence for an early start of these therapies is only available for dual platelet therapy and statins, whereas data on beta blockers and RAAS inhibitors are heterogenous and...

Full description

Bibliographic Details
Main Authors: Dirk von Lewinski, Ewald Kolesnik, Faisal Aziz, Martin Benedikt, Norbert J. Tripolt, Markus Wallner, Peter N. Pferschy, Friederike von Lewinski, Nora Schwegel, Rury R. Holman, Abderrahim Oulhaj, Deddo Moertl, Jolanta Siller-Matula, Harald Sourij
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Cardiovascular Diabetology
Subjects:
Myocardial infarction
SGLT2i
Timing
Clinical trial
Online Access:https://doi.org/10.1186/s12933-023-02000-5

Internet

https://doi.org/10.1186/s12933-023-02000-5

Similar Items